T 1262/22 (Fibrosis/SINGAPORE HEALTH SERVICES) of 17.09.2024

European Case Law Identifier: ECLI:EP:BA:2024:T126222.20240917
Date of decision: 17 September 2024
Case number: T 1262/22
Petition for review of: -
Application number: 16822941.7
IPC class: A61K 39/00 C07K 16/28 C07K 16/24 C12N 15/113 C07K 14/54 C07K 14/715
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: Abstract on Article 134 EPC
Application title: Treatment of fibrosis
Applicant name: Singapore Health Services Pte Ltd
National University of Singapore
Opponent name: Bayer Aktiengesellschaft
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 100(a)European Patent Convention Art 108 European Patent Convention Art 56 European Patent Convention R 152(6)
Keywords: Appeal validly filed
Authorisation of the professional representative filing the notice of appeal
Inventive step - no
Catchword: -
Cited cases: T 1685/08 T 1846/11 T 0924/17
Citing cases: -

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.